These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 26254012)

  • 21. [Prognostic significance of epidermoid metaplasia in urothelial carcinoma of the bladder].
    Vecchioli Scaldazza C; Morosetti D
    Arch Esp Urol; 1994 Sep; 47(7):671-3. PubMed ID: 7802470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Divergent differentiation in urothelial carcinoma and other bladder cancer subtypes with selected mimics.
    Shanks JH; Iczkowski KA
    Histopathology; 2009 Jun; 54(7):885-900. PubMed ID: 19178589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of histological reclassification during pathology re-review--evidence of a Will Rogers effect in bladder cancer?
    Linder BJ; Boorjian SA; Cheville JC; Sukov WR; Thapa P; Tarrell RF; Frank I
    J Urol; 2013 Nov; 190(5):1692-6. PubMed ID: 23707452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histopathology of urinary bladder carcinoma: less common variants.
    Damjanov I; Golubović M
    Srp Arh Celok Lek; 2011; 139(9-10):693-9. PubMed ID: 22070010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Invasive micropapillary urothelial carcinoma of the bladder.
    Lopez-Beltran A; Montironi R; Blanca A; Cheng L
    Hum Pathol; 2010 Aug; 41(8):1159-64. PubMed ID: 20381120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
    Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of squamous histology in bladder cancer: a population-based study.
    Izard JP; Siemens DR; Mackillop WJ; Wei X; Leveridge MJ; Berman DM; Peng Y; Booth CM
    Urol Oncol; 2015 Oct; 33(10):425.e7-13. PubMed ID: 26199176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unusual forms of carcinoma of the urinary bladder.
    Young RH; Eble JN
    Hum Pathol; 1991 Oct; 22(10):948-65. PubMed ID: 1842384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histological patterns of cancer of the urinary bladder in Indians.
    Doctor VM; Sirsat MV
    Indian J Cancer; 1970 Jun; 7(2):81-9. PubMed ID: 5507063
    [No Abstract]   [Full Text] [Related]  

  • 30. Expression of caveolin-1 and caveolin-2 in urothelial carcinoma of the urinary bladder correlates with tumor grade and squamous differentiation.
    Fong A; Garcia E; Gwynn L; Lisanti MP; Fazzari MJ; Li M
    Am J Clin Pathol; 2003 Jul; 120(1):93-100. PubMed ID: 12866378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Nested variant urothelial carcinoma: diagnostic difficulties].
    Berthier A; Gobet F; Bugel H; Roquet L; Pfister C
    Prog Urol; 2005 Sep; 15(4):729-32. PubMed ID: 16459696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Detection of squamous cell differentiation in experimental tumors of urothelium by using epidermal G2 chalone].
    Anichkov NM; Vlasov NN; Okulov VB
    Arkh Patol; 1981; 43(4):82-4. PubMed ID: 6453574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Bladder tumor histo-seminar - case 3: Urinary cytology. Atypical urothelial cells, cannot exclude high grade (AUC-H) or "suspicious for high-grade urothelial carcinoma" (SHGUC of the Paris classification)].
    Piaton E
    Ann Pathol; 2016 Dec; 36(6):382-385. PubMed ID: 27838073
    [No Abstract]   [Full Text] [Related]  

  • 34. [A case of transitional cell carcinoma with squamous differentiation which developed squamous cell carcinoma in situ in the clinical course].
    Sugiura S; Makiyama K; Yokomizo Y; Umemoto S; Miyoshi Y; Nakaigawa N; Ogawa T; Uemurai H; Yao M; Kubota Y; Yamanaka S
    Hinyokika Kiyo; 2006 Sep; 52(9):715-8. PubMed ID: 17040058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma.
    Moussa M; Omran Z; Nosseir M; Lotfy A; Swellam T
    APMIS; 2009 Jan; 117(1):45-52. PubMed ID: 19161536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel markers of squamous differentiation in the urinary bladder.
    Huang W; Williamson SR; Rao Q; Lopez-Beltran A; Montironi R; Eble JN; Grignon DJ; Idrees MT; Emerson RE; Zhou XJ; Zhang S; Baldridge LA; Hahn NM; Wang M; Koch MO; Cheng L
    Hum Pathol; 2013 Oct; 44(10):1989-97. PubMed ID: 23806524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On the capillary vascular bed in carcinoma of the urinary bladder.
    Omar AH; Shalaby MA; Ibrahim AH
    East Afr Med J; 1975 Jan; 52(1):34-41. PubMed ID: 1140129
    [No Abstract]   [Full Text] [Related]  

  • 38. Histopathology and classification of urinary bladder carcinoma.
    Friedell GH; Bell JR; Burney SW; Soto EA; Tiltman AJ
    Urol Clin North Am; 1976 Feb; 3(1):53-70. PubMed ID: 936368
    [No Abstract]   [Full Text] [Related]  

  • 39. [Histological structure and prognosis in carcinoma of the bladder].
    Raĭchev R; Sakhatchiev A; Peĭkov Ts; Mushmov M; Krusteva
    Khirurgiia (Sofiia); 1977; 30(2):144-52. PubMed ID: 916566
    [No Abstract]   [Full Text] [Related]  

  • 40. Pathologic study on total cystectomy specimens of bladder cancer.
    Tang SE; Chen LZ; Zou WZ; Gu FL
    Chin Med J (Engl); 1985 Sep; 98(9):643-8. PubMed ID: 3938378
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.